Publication:
An Appraisal of Measles Vaccines

dc.contributor.authorTan, Seong Chanen_US
dc.date.accessioned2024-03-13T02:32:14Z
dc.date.available2024-03-13T02:32:14Z
dc.date.issued1984
dc.description43 p. : graphs, tables ; 30cm, Accession No.: DMM0000143 -- DMM0000144en_US
dc.description.abstractImmunization against measles has become a feasible proposition with the development of live attenuated, killed, and further attenuated live vaccines in tissue cultures. The former two classes of vaccines are effective buat are associated with many side reactions. The latter is effective and safe. Immunization programmes undertaken by many countries have demonstrated the value of measles vaccines in protecting the individuals, controlling the disease and saving costs. Occurrence of outbreaks in immunized populations is mainly due to administrative, technical and attitudinal problems which can be solved. Adequate resources must be available to exploit the vaccine foe effective control of the disease. There is no biologic reason why measles cannot be eradicated with the use of vaccine with aids from their developed conterparts.en_US
dc.identifier.urihttps://library.nih.gov.my/e-doc/flipbook/thesis/dmm/143-144/index.html
dc.identifier.urihttps://repository.nih.gov.my/handle/123456789/70
dc.language.isoenen_US
dc.publisherKuala Lumpur: Institute for Medical Researchen_US
dc.relation(Seameo-Tropmed) Institute for Medical Research. Diploma in Medical Microbiology. 1983-1984en_US
dc.subjectDissertations, Academicen_US
dc.subjectMeasles Vaccineen_US
dc.subjectMeasles vaccine -- Dissertationsen_US
dc.titleAn Appraisal of Measles Vaccinesen_US
dc.typeThesisen_US
dspace.entity.typePublication
Files